« Previous
Next »
Journal of Pediatric Health Care
Volume 24, Issue 2
, Pages 127-132
, March 2010
Individualizing Treatment for Adolescent Acne to Achieve Optimal Outcomes
References
- . Tricks for improving compliance with acne therapy. Dermatologic Therapy. 2006;19:224–236
- . Predictors of healthcare outcomes and costs related to medication use in patients with acne in the United States. Cutis. 2006;77:251–255
- . Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. British Journal of Dermatology. 2002;146:840–848
- . A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clinical Therapeutics. 2002;24:1117–1133
- . Effectiveness of oral antibiotics and topical retinoid therapy in the treatment of acne in adolescents. Pediatric Nursing. 2001;27:410–411421
- Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris. Cutis. 2001;67(2 Suppl.):13–20
- Management of acne: A report from a Global Alliance to Improve Outcomes in Acne. Journal of the American Academy of Dermatology. 2003;49(1 Suppl.):S1–S37
- . Guidelines for the management of acne vulgaris in adolescents. Paediatric Drugs. 2003;5:301–313
- . Hormonal therapy for acne using oral contraceptive pills. Seminars in Cutaneous Medicine and Surgery. 2005;24:103–106
- . Managing adolescent acne: A guide for pediatricians. Pediatrics in Review. 2005;26:250–261
- . Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris. American Journal of Clinical Dermatology. 2001;2:33–39
- . A randomized, open-label, comparative study of oral doxycycline 100 mg vs. 5% topical benzoyl peroxide in the treatment of mild to moderate acne vulgaris. International Journal of Dermatology. 2006;45:1438–1439
- . Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. British Journal of Dermatology. 1998;139(Suppl. 52):8–11
- . The stability of tretinoin in tretinoin gel microsphere 0.1%. Cutis. 2002;70:295–298
- . Acne: Intervene early. The Nurse Practitioner. 2006;31:24–43
- Antibiotic-resistant acne: Lessons from Europe. British Journal of Dermatology. 2003;148:467–478
- . Contraindications to oral contraceptive use among women in the United States, 1999-2001. Contraception. 2007;75:355–360
- Guidelines of care for acne vulgaris management. Journal of the American Academy of Dermatology. 2007;56:651–663
- . Minocycline and lupuslike syndrome in acne patients. Archives of Internal Medicine. 1999;159:493–497
- . Acne vulgaris: A review of antibiotic therapy. Expert Opinion on Pharmacotherapy. 2005;6:409–418
- . Psychosocial impact of acne vulgaris: Evaluating the evidence. Skin Therapy Letter. 2004;9:1–39
- . Benzoyl peroxide-based combination therapies for acne vulgaris: A comparative review. American Journal of Clinical Dermatology. 2004;5:261–265
- New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group. Journal of the American Academy of Dermatology. 2009;60:S1–S50
- . Addressing patient variability: Clinical challenges in the initiation of acne treatment. Cutis. 2008;82(2 Suppl.):9–17
- A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris. Cutis. 2001;67:165–169
- . Clindamycin/benzoyl peroxide gel: A review of its use in the management of acne. American Journal of Clinical Dermatology. 2002;3:349–360
- . Current concepts in acne management. Adolescent Medicine Clinics. 2006;17:613–637
- . Expert committee recommendations for acne management. Pediatrics. 2006;118:1188–1199
Dermik Laboratories, a business of Sanofi-Aventis U.S. LLC, provided funding to Peloton Advantage, LLC, in order to support the development of this article. Peloton Advantage assisted with fact-checking, editing, and preparing the manuscript for submission. The opinions expressed in the current article are those of the authors. The authors received no honoraria or other form of financial support related to the development of this manuscript. Lara A. Clayton, MPAS, PA-C, and Wynnis L. Tom, MD, have no financial conflicts of interest to report.
PII: S0891-5245(09)00177-1
doi: 10.1016/j.pedhc.2009.06.003
« Previous
Next »
Journal of Pediatric Health Care
Volume 24, Issue 2
, Pages 127-132
, March 2010
